Lamotrigine Therapy for Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

Journal of Autism and Developmental Disorders

Volumn 31, Issue 2, 2001, Pages 175-181

  Belsito, Karin M ^a   Law, Paul A ^b   Kirk, Karen S ^a   Landa, Rebecca J ^a,b   Zimmerman, Andrew W ^a,b  

^a KENNEDY KRIEGER INSTITUTE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Autism; Lamotrigine

Indexed keywords

GLUTAMATE RECEPTOR; LAMOTRIGINE; PLACEBO; AMINO ACID RECEPTOR BLOCKING AGENT; GLUTAMIC ACID; TRIAZINE DERIVATIVE;

ADAPTATION; ARTICLE; AUTISM; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEVELOPMENTAL DISORDER; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTRANSMITTER RELEASE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RECEPTOR UPREGULATION; RISK BENEFIT ANALYSIS; SOCIAL INTERACTION; ANALYSIS OF VARIANCE; AUTISTIC DISORDER; BLOOD; CHILD BEHAVIOR; DRUG EFFECTS; METABOLISM; PRESCHOOL CHILD; PSYCHOLOGICAL RATING SCALE;

ANALYSIS OF VARIANCE; AUTISTIC DISORDER; CHILD; CHILD BEHAVIOR; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLUTAMIC ACID; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; TRIAZINES;

EID: 0035321893     PISSN: 01623257     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010799115457     Document Type: Article

References (22)

1. Aman, M. G., Singh, N. N., Stewart A.W., & Field, C. J. (1985). The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiency, 89(5), 485-491.
2. Bauman, M. L., and Kemper, T. L. (1984). Neuroanatomic observations of the brain in autism. In M. L. Bauman, & T. L. Kemper (Eds.), The neurobiology of autism (pp. 119-145). Baltimore: The Johns Hopkins University Press.
3. Bittigau, P., & Ikonomidou, C. (1997). Glutamate in neurologic diseases. Journal of Child Neurology, 12, 471-485.
4. Brodie, M. (1992). Lamotrigine. Lancet, 339, 1397-1400.
5. Buoni, S., Grosso, S., & Fois, A. (1998). Lamotrigine treatment in childhood drug resistant epilepsy. Journal of Child Neurology, 13, 163-167.
6. Coulter, D. A. (1997). Antiepileptic drug cellular mechanisms of action: where does lamotrigine fit in? Journal of Child Neurology, 12(Suppl. 1), S2-9.
7. Delong, R. (1994). Children with autistic spectrum disorder and a family history of affective disorder. Developmental Medicine and Child Neurology, 36, 659-660.
8. DiLavore, P. C., Lord, C., & Rutter, M. (1995). The pre-linguistic autism diagnostic observation schedule. Journal of Autism and Developmental Disorders, 25(4), 355-379.
9. Herrling, P. L. (ed.). (1997). Excitatory amino acids: clinical results with antagonists. San Diego, CA: Academic Press.
10. Kornhuber, J., Mack-Burkhardt, F., Konradi, C., Fritze, J., & Riderer, P. (1989). Effect of antemortem and postmortem factors on [3H]MK-801 binding in the human brain: Transient elevation during early childhood. Life Science, 45, 745-749.
11. Kotler, M., & Matar, M. A. (1998). Lamotrigine in the treatment of resistant bipolar disorder. Clinical Neuropharmacology, 21(1), 65-67.
12. Krug, D. A., Arick, J., & Almond, P. (1993). Autism Behavior Checklist Record Form. Austin Texas: PRO-ED, Inc.
13. Lord, C., Rutter, M., Goode, S., Heemsbergen, J., Jordan, H., Mawhood, L., & Schopler, E. (1989). Autism diagnostic observation schedule: a standardized observation of communicative and social behavior. Journal of Autism and Developmental Disorders, 19, 185-212.
14. Lord, C., Rutter, M., & LeCouteur, A. (1994). Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24, 659-685.
15. Monaghan, D. T., & Cotman, C. W. (1985). Distribution of NMDA-sensitive L-3H-glutamate binding sites in rat brain as determined by quantitative autoradiography. Journal of Neuroscience, 5, 2909-2919.
16. Rapin, I., & Katzman, R. (1998). Neurobiology of autism. Annals of Neurology, 43, 7-14.
17. Raymond, G., Bauman, M., & Kemper, T. L. (1996). Hippocampus in autism: A Golgi analysis. Acta Neuropathologica, 91, 117-119.
18. Schopler, E., Reichler, R., & Renner, B. (1988). Childhood Autism Rating Scale (CARS). Los Angeles: Western Psychological Services.
19. Sparrow, S. S., Balla, D. A., & Cicchetti, D. V. (1984). Vineland Adaptive Behavior Scales; Interview Edition Survey Form. Circle Pines, Minnesota: American Guidance Service, Inc.
20. Sporn, J., & Sachs, G. (1997). The anticonvulsant lamotrigine in treatment-resistent manic-depressive illness. Journal of Clinical Psychopharmacology, 17, 85-89.
21. Uldall, P., Hansen, F. J., & Tonnby, B. (1993). Lamotrigine in Rett syndrome. Neuropediatrics, 24, 339-340.
22. Uvebrant, P., & Bauziene, R. (1994). Intractable epilepsy in children. The efficacy of lamotrigine treatment including nonsiezure-related benefits. Neuropediatrics, 25, 284-289.